Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Advances in leadless pacemaker technology have enabled accelerometer-based atrioventricular (AV) synchronous pacing by sensing atrial mechanical contraction.
Objective: The purpose of this study was to report the performance of the Micra AV leadless pacemaker from the worldwide Micra AV post-approval registry (PAR) through 12 months.
Methods: The Micra AV PAR is a prospective, single-arm, observational registry designed to assess the safety and effectiveness of Micra AV in a real-world setting. For the present interim analysis, major complications and system revisions through 12 months were summarized and compared to a historical cohort of 2667 patients implanted with a transvenous dual-chamber pacing system.
Results: The device was successfully implanted in 796 of 801 patients (99.4%) at 97 centers in 19 countries. Micra AV patients were older (74.1 years vs 71.1 years; P < .0001) with a higher incidence of renal disease (22.3% vs 9.8%; P < .0001) compared with transvenous dual-chamber patients. Through 12 months, the major complication rate was 3.7% in Micra AV patients compared with 8.8% in transvenous dual-chamber patients (hazard ratio 0.42; 95% confidence interval 0.28-0.61; P < .001). The system revision rate was 1.5% in Micra AV patients compared with 5.5% for transvenous dual-chamber patients (hazard ratio 0.25; 95% confidence interval 0.13-0.47; P < .001); this reduction was largely driven by the absence of lead dislodgments requiring revision. The median AV synchrony index was 79.4% (interquartile range 65.2%-86.4%) in patients paced >90%.
Conclusion: The Micra AV leadless pacemaker was implanted with a high rate of success in patients with multiple comorbidities, with a significantly lower rate of complications and system revisions through 12 months compared to a historical cohort of patients with transvenous dual-chamber pacemakers.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.hrthm.2024.06.008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An Unusual Presentation of Third-Degree Atrioventricular Block in a Patient With Hypertrophic Cardiomyopathy.
Cureus
July 2025
Adult Cardiology, Uganda Heart Institute, Kampala, UGA.
Patients with hypertrophic cardiomyopathy (HCM) are commonly affected by ventricular tachyarrhythmias such as ventricular tachycardia, leading to syncope and sudden cardiac death (SCD). Complete atrioventricular (AV) block in patients with HCM is very unusual but may also lead to syncope and SCD. We report a 52-year-old male who presented with recurrent episodes of pre-syncope and effort intolerance.
View Article and Find Full Text PDFLeadless pacing: Technology, techniques, and emerging options.
Prog Cardiovasc Dis
July 2025
Emory University School of Medicine, Department of Medicine, Division of Cardiology-Section of Electrophysiology, Atlanta, GA, USA. Electronic address:
Leadless pacemakers offer several advantages over transvenous pacemakers. They mainly reduce lead and pocket related complications which result in a reduction of re-intervention and infection rates (Graphical abstract). However, leadless pacemakers are not without drawbacks.
View Article and Find Full Text PDFA case with combination of pyoderma gangrenosum and cardiac sarcoidosis successfully implanted with a dual-chamber pacemaker.
J Cardiol Cases
June 2025
Department of Cardiovascular Medicine, and Endocrinology and Metabolism, Faculty of Medicine, Tottori University, Yonago, Japan.
Unlabelled: A patient with ulcerated skin lesions of unknown etiology on his left leg underwent pacemaker implantation for atrioventricular block caused by cardiac sarcoidosis (CS). After initiation of corticosteroid for CS, his skin lesions improved. The lesions were diagnosed as pyoderma gangrenosum (PG) from the findings of a skin biopsy and the reaction to corticosteroid.
View Article and Find Full Text PDFPacemaker Lead Perforation Presenting as Persistent Abdominal Pain: A Case Report.
Cureus
May 2025
Emergency Medicine, Mayo Clinic Arizona, Phoenix, USA.
Cardiac pacemakers are widely used, and lead perforation is a rare but serious complication that may present atypically, leading to diagnostic challenges. We present the case of a 79-year-old male with a history of multiple comorbidities, including heart failure with preserved ejection fraction, right bundle branch block, and recent dual-chamber pacemaker implantation, who developed persistent left upper quadrant abdominal pain. Despite multiple ED visits and specialist evaluations, no clear etiology was identified.
View Article and Find Full Text PDFDual-chamber leadless pacing with Aveir DR offers a breakthrough alternative for patients at high risk of infection or with limited vascular access. By enabling both atrial and ventricular pacing without transvenous leads, this technology improves AV synchrony and may revolutionize future cardiac rhythm management, including defibrillation and resynchronization therapies.
View Article and Find Full Text PDF